Monica Jimenez Hernandez. MD PhD
Barcelona
Summary
Professional with over 15 years of pharmaceutical experience. Hematologist physician and Ph.D. Experience in clinical research, drug development and leading medical teams. Strategic and innovative mindset. I am passionate about bringing new hope to patients.
Overview
23
23
years of professional experience
Work History
Consultant Hematologist
Clinical Trials Unit. Hematology Service. Catalan Institute of Oncology
05.2024 - Current
- 4Coinvestigator of over 40 clinical trials in hematological diseases (Lymphoma, Multiple Myeloma, CLL, MPD), including cell therapy, bispecific monoclonal antibodies and BTKi.
Medical Director
IDP-Discovery Pharma
01.2024 - 05.2024
- Responsible for monitoring and interpreting data, and for ongoing safety surveillance
- Accountable for developing/writing Study protocol, Study Execution, & Study Interpretation.
Director of Hematology Unit
Echevarne Lab
10.2023 - 05.2024
- Technical work as a hematologist
- People management.
- Developed high-performing teams by providing mentorship, guidance, and opportunities for professional growth.
Global Medical Advisor Innovative Oncology
Pierre Fabre Medicament
04.2023 - 09.2023
- Responsible for expanded access program, data generation and investigator-initiated studies support.
Therapeutic Area Head (CAR-T Therapy)
Novartis Oncology Spain
03.2018 - 01.2023
- Risk Management Plan for CART therapy
- People management (Cell Therapy Medical Managers)
- Responsibilities for the development of global studies at country level for phase I-III clinical trials
- Member of the European Medical Cell and Gene Leadership Team
- Achievements: Award for the best Novartis Oncology collaborator in 2018 (top performer), leadership of a cross-functional Scrum team.
Medical Advisor/Clinical Research Medical Advisor
Novartis Oncology Spain
09.2006 - 03.2018
- Medical responsible for several drugs: CTL019, deferasirox, eltrombopag, imatinib, panobinostat, etc
- Responsible for local data generation and investigator-initiated studies support
- Responsibilities for the development of global studies at the country level for global phase I-III clinical trials
- Achievements: Region Europe Award for leading innovation (team awarded with the best practice most implemented across Europe, 2011); Award for making things happen (Novartis Oncology Spain, 2014); Award values and Behaviors (Novartis Oncology Spain, 2017).
Attending Physician
Hematology Department. Hospital Vall d´Hebron
01.2004 - 01.2006
Researcher
The August Pi I Sunyer Biomedical Research Institute (IDIBAPS). Hospital Clinic Barcelona
01.2002 - 01.2006
- Development of the “Study of immune reconstitution after reduced intensity conditioning regimen hematopoietic stem cell transplantation”
- Achievements: PhD cum laude (May 2006).
Education
Ph. D. in Medicine -
Universidad de Barcelona
Course HMX Fundamentals: Immunology-Immuno-oncology -
Harvard Medical School
Professional Scrum Product Owner 1 (PSPO1) -
Scrum.org
Advanced Physician Medical Monitor Certification (APMMC) -
CCRPS
Master's degree in Statistics in Health Science (33 ECTS) -
Universidad Autónoma de Barcelona
01.2015
Medical Specialization in Hematology and Hemotherapy -
Hospital Clinic
01.2002
Degree in Medicine and Surgery -
Universidad De Barcelona
01.1997
Skills
- Problem-Solving
- Team Leadership & Development
- Integrity and Honesty
- Resilience
- Analytical thinking
- Team player
Languages
Spanish
native
English
fluent
Publications
- G. Perea, A. Remacha, C. Besses, M. Jiménez, et al. Is polycythemia vera a serious disease in young adults? Haematologica 2001; 86: 543-544.
- M. Jiménez, A. López-Guillermo, F. Cobo, et al. Bladder Involvement of Diffuse Large B-cell Lymphoma Diagnosed by a Cytological Study of the Urine. Leukemia and Lymphoma 2001;43: 187-189.
- J.C. Hernández-Boluda, M. Jiménez, L. Rosiñol, F. Cervantes. Idiopathic Myelofibrosis Associated with Primary Biliary Cirrhosis. Leukemia and Lymphoma 2002; 43:673-674.
- E. Nadal, A. Martínez, M. Jiménez, et al. Primary Follicular Lymphoma arising in the ampulla of Vater. Annals of Hematology 2002; 81:228-232.
- M. Jiménez, C. Sanz, A. Álvarez, A. Pereira. Massive intravascular hemolysis associated with Clostridium Perfringens septicemia. Vox sanguinis 2002; 82: 214, 2002.
- G. Perea, A. Altés, S. Montoto, A. López-Guillermo, F. Bosch, M. Jiménez, et al. International and Italian prognostic indices in follicular lymphoma. Haematologica 2003; 88:700-704.
- M. Rovira, M. Jiménez, et al. Detection of Aspergillus galactomannan by enzyme-linked immuno assay in allogeneic hematopoietic stem cell transplantation: a prospective study. Transplantation 2004; 77: 1260-1264.
- A. López-Guillermo, L. Colomo, M. Jiménez, et al. Diffuse Large B-Cell Lymphoma (DLBCL): Clinico biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin. Journal of Clinical Oncology 2005; 23: 2797-2840.
- M. Jiménez, C. Martínez, G. Ercilla, et al. Non-myeloablative Conditioning Regimen Preserves Thymic Function in the Early Period After Hematopoietic Stem Cell Transplantation. Experimental Hematology 2005; 33 (10): 1240-1248.
- E. Carreras, M. Jiménez, et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated hematopoietic cell transplantation for chronic myeloid leukemia. Bone Marrow Transplantation 2006;37(1):33-40.
- M. Jiménez, G. Ercilla, C. Martínez, E. Carreras, Á. Urbano, E. Montserrat. Immune reconstitution following non-myeloablative stem cell transplantation (Review). Leukemia 2007;21: 1628–1637.
- M. Jiménez, C. Martínez, G. Ercilla, et al. Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults. Transplant Immunology 2006; 16:52-59.
- C. Vallejo, M. Batlle, L. Vázquez, C. Solano, A. Sampol, R. Duarte, D.Hernández, J.López, M. Rovira, S. Jiménez, D. Valcárcel, V. Belloch, M. Jiménez, and I. Jarque. Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation. Haematologica 2014; 99(10): 1633-1637.
- EM. Ocio, J. Dávila, JC. Caballero, S. Alonso, VG. de la Calle, R. García-Sanz, L. Gazi, S. Opio, M. Jiménez, JF. San-Miguel, MV Mateos. Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma. Haematologica July 2015 100 (7): e289-e291.
- F. Ramos, C. Pedro, M. Tormo, R. de Paz, P. Fonte, E. Luño, M. Caballero, F. Solano, M. Almagro, B. Xicoy, M. Jiménez. Impact of anemia on health-related quality-of-life and cardiac remodeling in patients with lower-risk myelodysplastic syndromes. Results of GlobQoL study. European Journal of Cancer Care, 2017, 26, e12426, DOI: 10.1111/ecc.12426.
Timeline
Consultant Hematologist
Clinical Trials Unit. Hematology Service. Catalan Institute of Oncology
05.2024 - Current
Medical Director
IDP-Discovery Pharma
01.2024 - 05.2024
Director of Hematology Unit
Echevarne Lab
10.2023 - 05.2024
Global Medical Advisor Innovative Oncology
Pierre Fabre Medicament
04.2023 - 09.2023
Therapeutic Area Head (CAR-T Therapy)
Novartis Oncology Spain
03.2018 - 01.2023
Medical Advisor/Clinical Research Medical Advisor
Novartis Oncology Spain
09.2006 - 03.2018
Attending Physician
Hematology Department. Hospital Vall d´Hebron
01.2004 - 01.2006
Researcher
The August Pi I Sunyer Biomedical Research Institute (IDIBAPS). Hospital Clinic Barcelona
01.2002 - 01.2006
Ph. D. in Medicine -
Universidad de Barcelona
Course HMX Fundamentals: Immunology-Immuno-oncology -
Harvard Medical School
Professional Scrum Product Owner 1 (PSPO1) -
Scrum.org
Advanced Physician Medical Monitor Certification (APMMC) -
CCRPS
Master's degree in Statistics in Health Science (33 ECTS) -
Universidad Autónoma de Barcelona
Medical Specialization in Hematology and Hemotherapy -
Hospital Clinic
Degree in Medicine and Surgery -
Universidad De Barcelona
Similar Profiles
Christine ValdezChristine Valdez
Clinical Research Coordinator II at Kaiser Permanente Oncology Clinical TrialsClinical Research Coordinator II at Kaiser Permanente Oncology Clinical Trials
Charlotte AshmoreCharlotte Ashmore
Data entry clerk at University of Warwick Clinical trials unitData entry clerk at University of Warwick Clinical trials unit
Jasmyn AkaninworJasmyn Akaninwor
Clinical Study Coordinator at Interventional Clinical Trials Unit – UCLA Dept of UrologyClinical Study Coordinator at Interventional Clinical Trials Unit – UCLA Dept of Urology
OLAKUNLE OYERINDEOLAKUNLE OYERINDE
Senior Manager, IT Business Partner at CHIVITA HOLLANDIA INTERNATIONAL (A Member of the Coca-Cola Family)Senior Manager, IT Business Partner at CHIVITA HOLLANDIA INTERNATIONAL (A Member of the Coca-Cola Family)
Karina OrtizKarina Ortiz
KEY ACCOUNT MANAGER - SHRIMP at Sociedad Nacional De Galápagos - SONGAKEY ACCOUNT MANAGER - SHRIMP at Sociedad Nacional De Galápagos - SONGA